MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization
- PMID: 20093590
- DOI: 10.2214/AJR.09.3522
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization
Abstract
Objective: The purpose of this article is to describe the role of MR, CT, and PET/CT in the detection of ovarian cancer and the evaluation of adnexal lesions.
Conclusion: The goal of imaging in ovarian cancer detection is to expeditiously distinguish benign adnexal lesions from those requiring further pathologic evaluation for malignancy. For lesions indeterminate on ultrasound, MRI increases the specificity of imaging evaluation, thus decreasing benign resections. CT is useful in diagnosis and treatment planning of advanced cancer. Although (18)F-FDG-avid ovarian lesions in postmenopausal women are considered suspicious for malignancy, PET/CT is not recommended for primary cancer detection because of high false-positive rates.
Similar articles
-
Indirect comparison of the diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis.BMC Cancer. 2021 Oct 6;21(1):1080. doi: 10.1186/s12885-021-08815-3. BMC Cancer. 2021. PMID: 34615498 Free PMC article.
-
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.Invest Radiol. 2014 Aug;49(8):524-31. doi: 10.1097/RLI.0000000000000050. Invest Radiol. 2014. PMID: 24637584
-
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.Gynecol Oncol. 2000 Jun;77(3):454-9. doi: 10.1006/gyno.2000.5768. Gynecol Oncol. 2000. PMID: 10831359 Clinical Trial.
-
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings.Radiology. 2002 Jun;223(3):780-8. doi: 10.1148/radiol.2233001850. Radiology. 2002. PMID: 12034950
-
Role of PET/CT in ovarian cancer.AJR Am J Roentgenol. 2010 Jun;194(6):W464-70. doi: 10.2214/AJR.09.3843. AJR Am J Roentgenol. 2010. PMID: 20489063 Review.
Cited by
-
Imaging of pediatric ovarian tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29995. doi: 10.1002/pbc.29995. Epub 2022 Oct 2. Pediatr Blood Cancer. 2023. PMID: 36184758 Free PMC article.
-
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014. Front Oncol. 2014. PMID: 25478323 Free PMC article. Review.
-
MR imaging of ovarian masses: classification and differential diagnosis.Insights Imaging. 2016 Feb;7(1):21-41. doi: 10.1007/s13244-015-0455-4. Epub 2015 Dec 16. Insights Imaging. 2016. PMID: 26671276 Free PMC article.
-
Screening for ovarian cancer: imaging challenges and opportunities for improvement.Ultrasound Obstet Gynecol. 2018 Mar;51(3):293-303. doi: 10.1002/uog.17557. Ultrasound Obstet Gynecol. 2018. PMID: 28639753 Free PMC article.
-
Delayed presentation of a huge abdominopelvic mass during the COVID-19 pandemic.Ann Med Surg (Lond). 2022 Oct;82:104576. doi: 10.1016/j.amsu.2022.104576. Epub 2022 Sep 12. Ann Med Surg (Lond). 2022. PMID: 36117529 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical